|
AU2002321760B9
(en)
*
|
2001-07-20 |
2008-06-12 |
Absorber, Ab |
Blood group antigen fusion polypeptides and methods of use thereof
|
|
AU2003228067B2
(en)
*
|
2002-04-22 |
2008-05-29 |
Recopharma Ab |
Mucin fusion polypeptide vaccines, compositions and methods of use thereof
|
|
JP2005532793A
(ja)
*
|
2002-04-22 |
2005-11-04 |
レコファーマ アーベー |
微生物付着を阻害するための融合ポリペプチドおよび方法
|
|
EP1534725A2
(en)
|
2002-05-16 |
2005-06-01 |
Glycomimetics, Inc. |
Compounds and methods for inhibiting selectin-mediated function
|
|
WO2004004636A2
(en)
*
|
2002-07-03 |
2004-01-15 |
Glycomimetics, Inc. |
Compositions and methods for diagnosis and therapy of medical conditions involving angiogenesis
|
|
NZ538629A
(en)
*
|
2002-08-09 |
2008-05-30 |
Recopharma Ab |
Mucin-immunoglobulin fusion proteins
|
|
US20050076759A1
(en)
*
|
2003-10-08 |
2005-04-14 |
Brian Westfall |
Linear saw with stab-cut bevel capability
|
|
US20040219158A1
(en)
*
|
2003-05-02 |
2004-11-04 |
Glycomimetics, Inc. |
Compositions and methods for diagnosis and therapy of medical conditions involving infection with pseudomonas bacteria
|
|
US7459523B2
(en)
*
|
2003-11-12 |
2008-12-02 |
Wisconsin Alumni Research Foundation |
Equine P-selectin glycoprotein ligand-1 and uses thereof
|
|
WO2005054264A2
(en)
*
|
2003-11-19 |
2005-06-16 |
Glycomimetics, Inc. |
Glycomimetic antagonists for both e- and p-selectins
|
|
EP1763533B1
(en)
*
|
2003-11-19 |
2008-01-09 |
GlycoMimetics, Inc. |
Specific antagonist for both e- and p-selectins
|
|
CA2571852A1
(en)
*
|
2004-06-23 |
2006-01-05 |
Japan Science And Technology Agency |
Inhibition of infiltration, and cell killing agent
|
|
US8201377B2
(en)
*
|
2004-11-05 |
2012-06-19 |
Faus Group, Inc. |
Flooring system having multiple alignment points
|
|
WO2006127906A1
(en)
*
|
2005-05-25 |
2006-11-30 |
Glycomimetics, Inc. |
Heterobifunctional compounds for selectin inhibition
|
|
CA2618638C
(en)
*
|
2005-08-09 |
2014-03-11 |
Glycomimetics, Inc. |
Glycomimetic inhibitors of the pa-il lectin, pa-iil lectin or both the lectins from pseudomonas
|
|
PT1934236E
(pt)
|
2005-09-02 |
2012-12-26 |
Glycomimetics Inc |
Inibidores de pan-selectina heterobifuncionais
|
|
WO2007033221A2
(en)
*
|
2005-09-13 |
2007-03-22 |
The General Hospital Corporation |
Methods and compositions for inhibition of immune responses
|
|
ES2502966T3
(es)
*
|
2006-01-26 |
2014-10-06 |
Recopharma Ab |
Composiciones y métodos para inhibir la adhesión viral
|
|
US20070178447A1
(en)
*
|
2006-01-31 |
2007-08-02 |
Bethyl Laboratories, Inc. |
Method for decreasing interference in results of immunochemical methods
|
|
WO2007143052A1
(en)
*
|
2006-06-01 |
2007-12-13 |
Glycomimetics, Inc. |
Galactosides and thiodigalactosides as inhibitors of pa-il lectin from pseudomonas
|
|
WO2008060378A2
(en)
|
2006-10-12 |
2008-05-22 |
Glycomimetics, Inc. |
Glycomimetic replacements for hexoses and n-acetyl hexosamines
|
|
US7998486B2
(en)
|
2006-10-25 |
2011-08-16 |
Newlink Genetics Corporation |
Enhanced immunogenicity of tumor associated antigens by addition of alphaGal epitopes
|
|
WO2008100453A1
(en)
*
|
2007-02-09 |
2008-08-21 |
Glycomimetics, Inc. |
Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines
|
|
US8039442B2
(en)
|
2007-07-18 |
2011-10-18 |
Glycomimetics, Inc. |
Compounds and methods for treatment of sickle cell disease or complications associated therewith
|
|
US8895510B2
(en)
|
2008-04-08 |
2014-11-25 |
Glycomimetics, Inc. |
Pan-selectin inhibitor with enhanced pharmacokinetic activity
|
|
AU2009257536B2
(en)
*
|
2008-06-13 |
2015-07-02 |
Glycomimetics, Inc. |
Treatment of cancers of the blood using selected glycomimetic compounds
|
|
AU2010241807B2
(en)
|
2009-05-01 |
2014-08-14 |
Glycomimetics, Inc. |
Heterobifunctional inhibitors of E-selectins and CXCR4 chemokine receptors
|
|
US9420770B2
(en)
|
2009-12-01 |
2016-08-23 |
Indiana University Research & Technology Corporation |
Methods of modulating thrombocytopenia and modified transgenic pigs
|
|
US8921328B2
(en)
|
2010-09-14 |
2014-12-30 |
Glycomimetics, Inc. |
E-selectin antagonists
|
|
AU2011347237A1
(en)
*
|
2010-12-21 |
2013-07-11 |
Recopharma Ab |
Tear substitutes
|
|
EP3296310A1
(en)
|
2011-12-22 |
2018-03-21 |
GlycoMimetics, Inc. |
E-selectin antagonist compounds, compositions, and methods of use
|
|
HUE038423T2
(hu)
|
2012-12-07 |
2018-10-29 |
Glycomimetics Inc |
E-szelektin antagonistákat felhasználó vegyületek, készítmények és eljárások vérképzõ sejtek mobilizációjára
|
|
WO2016089872A1
(en)
|
2014-12-03 |
2016-06-09 |
Glycomimetics, Inc. |
Heterobifunctional inhibitors of e-selectins and cxcr4 chemokine receptors
|
|
US11045485B2
(en)
|
2016-01-22 |
2021-06-29 |
Glycomimetics, Inc. |
Glycomimetic inhibitors of PA-IL and PA-IIL lectins
|
|
WO2017151708A1
(en)
|
2016-03-02 |
2017-09-08 |
Glycomimetics, Inc. |
Methods for the treatment and/or prevention of cardiovescular disease by inhibition of e-selectin
|
|
WO2018031445A1
(en)
|
2016-08-08 |
2018-02-15 |
Glycomimetics, Inc. |
Combination of t-cell checkpoint inhibitors with inhibitors of e-selectin or cxcr4, or with heterobifunctional inhibitors of both e-selectin and cxcr4
|
|
WO2018068010A1
(en)
|
2016-10-07 |
2018-04-12 |
Glycomimetics, Inc. |
Highly potent multimeric e-selectin antagonists
|
|
EP3596096A1
(en)
|
2017-03-15 |
2020-01-22 |
GlycoMimetics, Inc. |
Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists
|
|
WO2019108750A1
(en)
|
2017-11-30 |
2019-06-06 |
Glycomimetics, Inc. |
Methods of mobilizing marrow infiltrating lymphocytes and uses thereof
|
|
JP7304863B2
(ja)
|
2017-12-29 |
2023-07-07 |
グリコミメティクス， インコーポレイテッド |
Ｅ－セレクチンおよびガレクチン－３のヘテロ二機能性阻害剤
|
|
CA3091454A1
(en)
|
2018-03-05 |
2019-09-12 |
Glycomimetics, Inc. |
Methods for treating acute myeloid leukemia and related conditions
|
|
US20210260250A1
(en)
*
|
2018-06-12 |
2021-08-26 |
Rush University Medical Center |
Methods for Enhanced Endothelialization of Implanted Material
|
|
US11845771B2
(en)
|
2018-12-27 |
2023-12-19 |
Glycomimetics, Inc. |
Heterobifunctional inhibitors of E-selectin and galectin-3
|
